Results 21 to 30 of about 85,612 (164)
eNeurologicalSci, 2022 Migraine is prevalent, disabling, and peaks during people's peak productive years. The impact of migraine on people's professional lives, work productivity, and interpersonal relationships at work eventually affects everyone, has a significant ...
Olivia Begasse de Dhaem, Fumihiko Sakai
doaj +1 more source
Selectivity in genetic association with sub-classified migraine in women. [PDF]
PLoS Genetics, 2014 Migraine can be sub-classified not only according to presence of migraine aura (MA) or absence of migraine aura (MO), but also by additional features accompanying migraine attacks, e.g. photophobia, phonophobia, nausea, etc.
Daniel I Chasman +6 more
doaj +1 more source
Chronic Migraine Pathophysiology and Treatment: A Review of Current Perspectives
Frontiers in Pain Research, 2021 Chronic migraine is a disabling neurological disorder that imposes a considerable burden on individual and socioeconomic outcomes. Chronic migraine is defined as headaches occurring on at least 15 days per month with at least eight of these fulfilling ...
Tiffani J. Mungoven +2 more
doaj +1 more source
Pain and TherapyIntroduction Monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) or its receptor represent a major advance in migraine prevention. However, standardized criteria for assessing treatment response are lacking.
Carl H. Göbel +5 more
doaj +1 more source
Epilepsy & Behavior ReportsClinical studies have shown cenobamate (CNB) is effective for treating drug-resistant focal epilepsy. This study examines Polish patients with epilepsy, assessing the efficacy and safety of CNB at 200 mg/day and factors influencing early therapeutic ...
Ewa Czapińska-Ciepiela +3 more
doaj +1 more source
Estimation of migraine prevalence considering active and inactive states across different age groups
The Journal of Headache and Pain, 2023 Background Migraine is a very common headache disorder on the population level, characterized by symptomatic attacks (activity). For many people with migraine, the migraine symptoms intermittently or permanently cease during their lifetime (inactive ...
Marco Piccininni +3 more
doaj +1 more source
Rizatriptan as an Over-the-Counter Triptan in the Treatment of Migraine Attacks
Pain and TherapyAround 91% of migraine patients use over-the-counter medicines to treat attacks, often without further treatment or medical consultation. This therapeutic principle is established in most countries, regardless of how the healthcare system is otherwise ...
Carl H. Göbel +3 more
doaj +1 more source
The Chronic Migraine Brain: What Have We Learned From Neuroimaging?
Frontiers in Neurology, 2020 Chronic migraine is a highly disabling disease with a great impact on socioeconomic functioning and quality of life of migraine patients. Chronic migraine usually evolves from episodic migraine that gradually increases in attack frequency, supporting the
Massimo Filippi +4 more
doaj +1 more source
Frontiers in Neurology, 2023 BackgroundMigraine without aura (MwoA) is often mistaken for rhinosinusitis. The purpose of this study was to assess the prevalence of sinonasal symptoms, sinusitis-targeting medication use and burden of migraine in a large group of people with MwoA ...
Marcin Straburzynski +5 more
doaj +1 more source
VaccinesBackground/Objectives: In this ongoing, multicenter, global cohort observational study, phenotypes of headaches after COVID-19 vaccination were directly compared between different vaccines. Methods: Phenotypes of postvaccinal headache were recorded in 18,
Carl Hartmut Göbel +13 more
doaj +1 more source